Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,630.00
Bid: 2,610.00
Ask: 2,625.00
Change: 60.00 (2.33%)
Spread: 15.00 (0.575%)
Open: 2,525.00
High: 2,630.00
Low: 2,525.00
Prev. Close: 2,570.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Steve Crummett as Finance Director

10 Jan 2013 07:00

RNS Number : 2188V
Morgan Sindall Group PLC
10 January 2013
 



 

10 January 2013

 

Morgan Sindall Group plc: Appointment of Steve Crummett as Finance Director

 

The Board of Morgan Sindall Group plc ('Morgan Sindall' or the 'Group') today announces the appointment of Steve Crummett as Finance Director with effect from 25 February 2013. Current Finance Director, David Mulligan, has indicated that, after fifteen years with the Group, he would like to step down from his current role to pursue new challenges and, with the appointment of Steve Crummett, he will be leaving the Group on 10 April 2013 following a handover period.

 

Steve Crummett was most recently the Group Finance Director at Filtrona plc, a position he held from 2008. Prior to Filtrona, Steve held senior positions in a number of listed companies including Exel plc, Mckechnie plc and Logica plc. He qualified as a Chartered Accountant with Arthur Andersen. Steve is also a Non-Executive Director of Consort Medical plc.

 

Chairman, Adrian Martin, said:

 

'On behalf of the Board I would like to thank David Mulligan for his significant contribution and commitment to Morgan Sindall over the past fifteen years. In his time with us, David has been instrumental in developing strong reporting disciplines and controls and has been a collaborative and supportive member of the team.

 

I am delighted that we have recruited a person of Steve Crummett's calibre as Finance Director. He has gained substantial and wide-ranging experience across a number of businesses and has valuable and significant skills which are relevant to Morgan Sindall as the business continues to focus on growth opportunities for the medium to longer-term.'

 

 

 

-Ends -

 

There are no further details to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Crummett's appointment.

 

 

Morgan Sindall Group plc Tel: 020 7307 9200

Adrian Martin, Chairman

John Morgan, Chief Executive

 

Brunswick Tel: 0207 404 5959

Jonathan Glass

Nick Cosgrove

 

Notes to Editors:

 

Biography of Steve Crummett

 

From March 2008 to September 2012, Steve was the Group Finance Director of Filtrona plc, the FTSE 250 leading supplier of specialty plastic, fibre and foam products and was responsible for Finance, Tax, Treasury, IT, Internal Audit and Risk. From May 2007 to March 2008 he was Director of Corporate Development at Filtrona. Prior to Filtrona, Steve was at Exel plc from 2003 to 2006, through its acquisition by Deutsche Post. From 1997 to 2002, Steve was Head of Corporate Development at McKechnie plc, and Corporate Finance Manager at Logica plc from 1995 to 1997. He qualified as a Chartered Accountant with Arthur Andersen.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 7,000 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGGMLLVGFZM
Date   Source Headline
14th Jun 20239:13 amRNSHolding(s) in Company
12th Jun 20233:50 pmRNSHolding(s) in Company
1st Jun 20239:16 amRNSTotal Voting Rights
31st May 20234:10 pmRNSHolding(s) in Company
10th May 202311:19 amRNSAdditional Listing
5th May 20232:38 pmRNSHolding(s) in Company
4th May 202312:44 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
20th Apr 202310:24 amRNSBlock listing Interim Review
23rd Mar 20231:51 pmRNSAnnual Financial Report
21st Mar 20234:24 pmRNSAdditional Listing
16th Mar 20233:34 pmRNSDirector/PDMR Shareholding
16th Mar 20231:52 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSUK Government Self Remediation Contract
13th Mar 20232:40 pmRNSDirector/PDMR Shareholding
3rd Mar 202311:58 amRNSDirector/PDMR Shareholding
3rd Mar 202311:57 amRNSDirector/PDMR Shareholding
2nd Mar 20234:42 pmRNSDirector/PDMR Shareholding
2nd Mar 20234:41 pmRNSDirector/PDMR Shareholding
1st Mar 202311:28 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSFinal Results
6th Feb 20237:00 amRNSNotice of Full Year Results
1st Feb 20231:04 pmRNSTotal Voting Rights
25th Jan 20232:59 pmRNSHolding(s) in Company
3rd Jan 20231:56 pmRNSTotal Voting Rights
12th Dec 20228:25 amRNSHolding(s) in Company
5th Dec 20223:37 pmRNSHolding(s) in Company
2nd Dec 20229:06 amRNSTotal Voting Rights
7th Nov 20224:08 pmRNSAGM Voting Update
2nd Nov 20227:00 amRNSTrading Update
1st Nov 20221:49 pmRNSTotal Voting Rights
20th Oct 202211:00 amRNSBlock listing Interim Review
18th Oct 20221:16 pmRNSAdditional Listing
3rd Oct 20221:51 pmRNSTotal Voting Rights
13th Sep 20223:27 pmRNSAdditional Listing
1st Sep 202210:43 amRNSTotal Voting Rights
19th Aug 202211:00 amRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSHalf-year Report
1st Aug 202210:16 amRNSTotal Voting Rights
11th Jul 20227:00 amRNSNotice of Results
1st Jul 202210:50 amRNSTotal Voting Rights
14th Jun 202212:51 pmRNSAdditional Listing
6th Jun 202212:00 pmRNSTotal Voting Rights
1st Jun 20223:49 pmRNSDirector Declaration
17th May 20221:47 pmRNSHolding(s) in Company
10th May 202211:23 amRNSAdditional Listing
5th May 20224:45 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Update
3rd May 20223:48 pmRNSTotal Voting Rights
20th Apr 202210:25 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.